Age-related macular degeneration (AMD) is one of the leading causes of blindness, affecting more than 10% of people over age 65 in developed countries. Drugs like Roche’s Lucentis, which plugs up leaky blood vessels in the eye that are characteristic of the “wet” form of the disease, can help, but there’s still a demand for
Wed, 10/21/2015 - 9:38am Cynthia Fox, Science Writer Embryonic stem (ES) cell-like stem cells made from adult cells—and morphed into eye cells—are not rejected by the immune system, according to “humanized mouse” data in Cell Stem Cell. Coming alongside news that the first UK macular degeneration patient received eye cells made from normal ES cells,
Amy Millen, associate professor of epidemiology and environmental health in the University at Buffalo's School of Public Health and Health Professions, is lead author on a paper published Aug. 27 in JAMA Ophthalmology. UB research shows women with two risk alleles and low D status are more likely to have the disease By David J.
August 11, 2015 By Jim Dryden APTE LABORATORY PHOTO In this image of the retina, normal blood vessels (green) surround a clump of new, abnormal vessels that has formed beneath the center of the retina. Scientists at Washington University School of Medicine in St. Louis have identified a molecular pathway that leads to the formation
Wed, 08/12/2015 - 10:00am Collin Binkley and Carla K. Johnson, Associated Press In this Aug. 10, 2015, photo, Dr. Akhilesh Pandey, a researcher at Johns Hopkins University, poses alongside a mass spectrometer in his laboratory in Baltimore. Pandey's research analyzes both adult and fetal tissue, and by identifying which proteins are present, he can get
Photo by L. Brian Stauffer Dr. Stephen Boppart led a team that developed a new medical imaging device that can see individual cells in the back of the eye to better diagnose and track disease. From left: postdoctoral researcher Yuan-Zhi Liu, graduate student Fredrick A. South, and professor Stephen Boppart. 6/22/2015 | Liz Ahlberg, Physical
RegenerativeMedicine.net, by Staff ~ July 2, 2013 Dr. Steven Little said, “This grant will further enable research that builds upon our ongoing collaboration with Qrono. It is an excellent example of how an academic-industry collaboration can enable better medications.” The National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH), awarded Qrono Inc.
April 2, 2013 - By Jim Dryden A new study raises the intriguing possibility that drugs prescribed to lower cholesterol may be effective against macular degeneration, a blinding eye disease. Researchers at Washington University School of Medicine in St. Louis have found that age-related macular degeneration, the leading cause of vision loss in Americans over 50, shares a
Tuesday, October 2, 2012 By: Staff ~ ScienceDaily An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers. The findings suggest that induced pluripotent stem (iPS) cells -- which are derived from adult human skin cells but
ACT Announces First Dry AMD Patient Treated with Higher Dosage of Embryonic Stem Cell-Derived RPE Cells
Thursday, August 2, 2012 By: Market Watch Wall Street Journal Patient with Dry Age-Related Macular Degeneration Injected with 100,000 Retinal Pigment Epithelial Cells at Wills Eye Institute in Philadelphia. MARLBOROUGH, Mass., Aug 02, 2012 (BUSINESS WIRE) -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment